JNL/Invesco Small Cap Growth I (FVUSA04AWV)

29.58 +0.36  +1.23% Jun 3 USD
View Full Chart
Total Returns Chart

Key Stats

Net Asset Value 29.58
Turnover Ratio 31.00%
1 Year Fund Level Flows -366.11M

Performance & Returns

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 18.37% 15.77% 38
3M 13.29% 2.70% 14
6M 8.75% 0.99% 26
YTD 5.61% -2.08% 26
1Y 19.03% 9.60% 25
3Y 10.65% 9.34% 44
5Y 8.73% 8.06% 46
10Y 13.27% 11.98% 31
15Y 9.95% 8.88% 34
20Y -- 7.13% --
As of June 3, 2020. Returns for periods of 1 year and above are annualized.

Asset Allocation

Type % Net % Long % Short
Cash 1.16% 1.16% 0.00%
Stock 98.84% 98.84% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.00% 0.00% 0.00%
Other 0.00% 0.00% 0.00%
As of March 31, 2020

Region Exposure

Americas 98.33%
North America 98.33%
Latin America 0.00%
Greater Europe 1.67%
United Kingdom 1.67%
Europe Developed 0.00%
Europe Emerging 0.00%
Africa/Middle East 0.00%
Greater Asia 0.00%
Japan 0.00%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 0.00%
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00%
As of March 31, 2020. Region breakdown data is calculated by using the long position holdings of the portfolio.

Stock Sector Exposure

Basic Materials 2.32%
Communication Services 2.43%
Consumer Cyclical 11.19%
Consumer Defensive 3.31%
Energy 0.33%
Financial Services 5.90%
Healthcare 29.86%
Industrials 14.34%
Real Estate 2.24%
Technology 28.08%
Utilities 0.00%
As of March 31, 2020

Stock Market Capitalization

Giant 0.00%
Large 2.08%
Medium 62.96%
Small 34.60%
Micro 0.36%
As of March 31, 2020

Stock Style Exposure

Large Cap Value 0.00%
Large Cap Blend 0.00%
Large Cap Growth 2.13%
Mid Cap Value 1.98%
Mid Cap Blend 15.93%
Mid Cap Growth 44.16%
Small Cap Value 3.23%
Small Cap Blend 8.36%
Small Cap Growth 24.21%
As of March 31, 2020
View More Holdings

Top 10 Holdings

Symbol Name % Weight Price % Chg
DXCM DexCom Inc 2.05% 365.86 -2.63%
RGEN Repligen Corp 1.94% 127.15 -4.66%
EHTH eHealth Inc 1.75% 128.73 -2.27%
CTLT Catalent Inc 1.71% 79.04 +1.32%
CHE Chemed Corp 1.67% 469.17 +0.62%
TECH Bio-Techne Corp 1.48% 259.43 -1.67%
QTWO Q2 Holdings Inc 1.40% 85.05 +0.88%
COR CoreSite Realty Corp 1.38% 119.77 -2.59%
RP RealPage Inc 1.23% 68.85 +1.22%
MASI Masimo Corp 1.21% 226.99 -3.24%
As of March 31, 2020
Advertisement

Basic Info

Investment Strategy
The investment seeks long-term growth of capital. The fund seeks to meet this objective by investing, normally, at least 80% of its assets (net assets plus the amount of any borrowings made for investment purposes) in securities of small-capitalization companies, at the time of purchase. The fund's manager considers a company to be a small-capitalization company if it has a market capitalization, at the time of purchase, no larger than the largest capitalized company included in the Russell 2000® Index during the most recent 11-month period (based on month-end data) plus the most recent data during the current month.
General
Security Type Mutual Fund
Oldest Share Symbol FVUSA00290
Equity Style Mid Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Small Growth
Prospectus Objective Small Company
Fund Owner Firm Name Jackson National
Benchmark Index
MSCI USA Small Growth GR USD 100.0%
Reports
One Page Report Download

Manager Info

Name Tenure
Clay Manley 12.24 yrs
Juan Hartsfield 15.34 yrs

Share Classes

Symbol Share Class
FVUSA00290 No Load

Net Fund Flows

1M -14.46M
3M -82.18M
6M -304.34M
YTD -170.24M
1Y -366.11M
3Y -367.20M
5Y -98.69M
10Y 608.33M
As of May 31, 2020

Risk Info

Beta (5Y) 1.228
Historical Sharpe Ratio (10Y) --
Historical Sortino (All) 0.406
Daily Value at Risk (VaR) 1% (All) 4.21%
Monthly Value at Risk (VaR) 1% (All) 27.97%

Fundamentals

Dividend Yield TTM (6-3-20) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Weighted Average PE Ratio 25.22
Weighted Average Price to Sales Ratio 2.198
Weighted Average Price to Book Ratio 3.597
Weighted Median ROE 9.43%
Weighted Median ROA 2.87%
Forecasted Dividend Yield 0.64%
Forecasted PE Ratio 22.12
Forecasted Price to Sales Ratio 1.991
Forecasted Price to Book Ratio 3.118
Number of Holdings 131
As of March 31, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth 12.12%
Forecasted Book Value Growth 11.92%
Forecasted Cash Flow Growth 11.18%
Forecasted Earnings Growth 9.87%
Forecasted Revenue Growth 7.49%
As of March 31, 2020

Comparables

Edit

Attributes

Purchase Details
Open to New Investors Yes
Open to Existing Investors Yes
Minimum Initial Investment 0.00 USD
Minimum Subsequent Investment 0.00 USD
Fees
Actual 12B-1 Fee 0.00%
Actual Management Fee 0.65%
Administration Fee 0.10%
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 3/5/2004
Termination Date
Last Annual Report Date 12/31/2019
Last Prospectus Date 4/27/2020
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Fixed Distribution Fund No
High-Net Worth Individual Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product Yes
Available for Retirement Plan Yes
Available for RRSP No
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.